Allworth Financial’s Zymeworks ZYME Stock Holding History

Allworth Financial’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.82K	Sell	108 -1	-0.9%	-$25	﹤0.01%	4377
2026 Q1	$2.73K	Sell	109 -37	-25%	-$875	﹤0.01%	4244
2025 Q4	$3.85K	Buy	146 +6	+4%	+$131	﹤0.01%	3862
2025 Q3	$2.39K	Buy	140 +18	+15%	+$258	﹤0.01%	3919
2025 Q2	$1.53K	Buy	122 +12	+11%	+$143	﹤0.01%	3815
2025 Q1	$1.38K	Buy	110 +76	+224%	+$1.04K	﹤0.01%	3350
2024 Q4	$499	Hold	34	–	–	﹤0.01%	3601
2024 Q3	$427	Hold	34	–	–	﹤0.01%	3454
2024 Q2	$333	Hold	34	–	–	﹤0.01%	3472
2024 Q1	$358	Hold	34	–	–	﹤0.01%	3369
2023 Q4	$354	Buy	+34	New	+$271	﹤0.01%	3202
2022 Q3	–	Sell	-92	Closed	–	–	3163
2022 Q2	$0	Hold	92	–	–	﹤0.01%	2879
2022 Q1	$1K	Sell	92 -22	-19%	-$196	﹤0.01%	2041
2021 Q4	$2K	Hold	114	–	–	﹤0.01%	1762
2021 Q3	$3K	Hold	114	–	–	﹤0.01%	1634
2021 Q2	$4K	Hold	114	–	–	﹤0.01%	1283
2021 Q1	$4K	Hold	114	–	–	﹤0.01%	1205
2020 Q4	$5K	Buy	+114	New	+$5.29K	﹤0.01%	1006

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Allworth Financial's ZYME Position: Q2 2026 in Review

Allworth Financial reduced its Zymeworks (ZYME) stake by 0.92% in Q2 2026, selling an estimated $25 and leaving 108 shares worth $2.82K. The position accounts for ﹤0.01% of the portfolio, ranked #4377.

Allworth Financial first reported a position in ZYME in Q4 2020 and has held it in 18 quarters since. The position peaked at $5K in Q4 2020. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

Allworth Financial held 108 shares of Zymeworks worth $2.82K as of Q2 2026.
Allworth Financial sold 1 Zymeworks share in Q2 2026, an estimated $25.
Zymeworks made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4377 holding.
Allworth Financial first reported a position in Zymeworks in Q4 2020 and has held it in 18 quarters since.
Allworth Financial's Zymeworks position peaked at $5K in Q4 2020.
202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.